Understanding The Biology and Function of RPA2: A Potential Drug Target Or Biomarker

Target Name: RPA2

NCBI ID: G6118

RPA2

Understanding The Biology and Function of RPA2: A Potential Drug Target Or Biomarker

Replication protein A2 (RPA2) is a protein that plays a crucial role in DNA replication and repair. It is a key component of the complex proteins that form the replication machinery, which is responsible for copying the genetic material from the DNA template to the new RNA template during the process of DNA replication. RPA2 is a well-known protein that has been extensively studied for its role in various biological processes, including DNA replication, cell division, and gene expression.

In recent years, there is growing interest in RPA2 as a potential drug target or biomarker. This is due to the discovery of new functions for RPA2, as well as the development of new technologies for its study. In this article, we will explore the biology and function of RPA2, as well as its potential as a drug target or biomarker.

Biology and Function of RPA2

RPA2 is a protein that consists of 194 amino acid residues. It belongs to the protein family of core DNA replication factors and is characterized by its ability to bind to specific DNA sequences. RPA2 is composed of two distinct regions: an N-terminal region that contains the protein's amino acid residues 2-90, and a C-terminal region that contains the protein's amino acid residues 91-194.

The N-terminal region of RPA2 contains a putative domain that is involved in the protein's binding to specific DNA sequences. This domain is composed of a nucleotide-binding oligomerization (NBO) domain, which is responsible for binding to DNA. The NBO domain is composed of a nucleotide-binding oligomerization domain and a structural domain that contains a hypervariable loop (HVL). The NBO domain is responsible for the protein's ability to bind to specific DNA sequences, as well as its role in regulating DNA replication.

The C-terminal region of RPA2 contains a region that is involved in the protein's interaction with the replication complex. This region is composed of a nucleotide-binding oligomerization domain, a domain that is involved in the regulation of DNA replication, and a structural domain that contains a hypervariable loop (HVL). The nucleotide-binding oligomerization domain is responsible for the protein's ability to bind to specific DNA sequences, while the domain that is involved in the regulation of DNA replication is responsible for regulating the activity of the replication complex.

RPA2 is also characterized by its ability to interact with the protein p53, which is a well-known tumor suppressor protein. This interaction between RPA2 and p53 plays a role in the regulation of DNA replication and is a potential target for cancer therapy.

Drug Targeting and Biomarker Potential

The discovery of new functions for RPA2 has led to the development of new technologies for its study. One of the most promising approaches for drug targeting RPA2 is the use of small molecules that can inhibit its activity. This is because the binding of small molecules to RPA2 is known to be sensitive to changes in the protein's activity state, making it an attractive target for drug development.

One of the most promising small molecules for drug targeting RPA2 is a compound called 2-fluoro-4-methoxybenzaldehyde (FMBA). FMBA is a derivative of the amino acid leucine, and has been shown to inhibit the activity of RPA2 in cell experiments. FMBA works by binding to a specific site on RPA2 that is involved in its activity.

Another promising small molecule for drug targeting RPA2 is a compound called N-acetyl-4-尾-mercaptopurine (NAP). NAP is an amino acid derivative that has been shown to inhibit the activity of RPA2 in cell

Protein Name: Replication Protein A2

Functions: As part of the heterotrimeric replication protein A complex (RPA/RP-A), binds and stabilizes single-stranded DNA intermediates, that form during DNA replication or upon DNA stress. It prevents their reannealing and in parallel, recruits and activates different proteins and complexes involved in DNA metabolism. Thereby, it plays an essential role both in DNA replication and the cellular response to DNA damage. In the cellular response to DNA damage, the RPA complex controls DNA repair and DNA damage checkpoint activation. Through recruitment of ATRIP activates the ATR kinase a master regulator of the DNA damage response. It is required for the recruitment of the DNA double-strand break repair factors RAD51 and RAD52 to chromatin in response to DNA damage. Also recruits to sites of DNA damage proteins like XPA and XPG that are involved in nucleotide excision repair and is required for this mechanism of DNA repair. Also plays a role in base excision repair (BER) probably through interaction with UNG. Also recruits SMARCAL1/HARP, which is involved in replication fork restart, to sites of DNA damage. May also play a role in telomere maintenance

The "RPA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets